Protia Inc. (KOSDAQ:303360)
South Korea · Delayed Price · Currency is KRW 3,900.00
-20.00 (-0.51%)
At close: Jun 30, 2026
Protia Market Cap
Protia has a market cap or net worth of 50.23 billion as of July 1, 2026. Its market cap has increased by 21.33% in one year.
Market Cap
50.23B
Enterprise Value
37.28B
Revenue
16.25B
Ranking
n/a
PE Ratio
12.51
Stock Price
3,900.00
Market Cap Chart
Since December 19, 2018, Protia's market cap has decreased from 78.41B to 50.23B, a decrease of -35.94%. That is a compound annual growth rate of -5.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 50.23B | -37.49% |
| Dec 30, 2025 | 80.35B | 127.74% |
| Dec 30, 2024 | 35.28B | -16.19% |
| Dec 28, 2023 | 42.10B | -45.57% |
| Dec 29, 2022 | 77.35B | 24.57% |
| Dec 30, 2021 | 62.09B | -38.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 197.35B |
| 3billion | 179.48B |
| GENINUS | 81.35B |
| Cytogen | 68.06B |
| Inventera | 63.32B |
| GC Medical Science | 62.07B |
| HLB Panagene | 59.64B |
| Seoulin Bioscience | 37.03B |